-+ 0.00%
-+ 0.00%
-+ 0.00%

Transgene to present SITC 2026 preclinical data on PoxSTG-EEV systemic oncolytic virus formulation

PUBT·10/05/2026 06:00:47
Listen to the news
Transgene to present SITC 2026 preclinical data on PoxSTG-EEV systemic oncolytic virus formulation
  • Transgene flagged new preclinical findings for PoxSTG-EEV, a novel enveloped oncolytic virus designed for systemic delivery.
  • Results have not been presented yet; the data are scheduled for a poster at the SITC 2026 annual meeting.
  • The poster is set for Nov. 7, 2026, in Phoenix, Arizona; the abstract is due online Nov. 3, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transgene SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610050200OMX_____CNEWS_EN_GNW1001276004_en) on October 05, 2026, and is solely responsible for the information contained therein.